nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A temporal perspective for tumor-associated macrophage identities and functions
|
Blériot, Camille |
|
|
42 |
5 |
p. 747-758 |
artikel |
2 |
Career trajectories of MD-PhD physician scientists: The loss of women investigators
|
Steinman, Richard A. |
|
|
42 |
5 |
p. 723-726 |
artikel |
3 |
Clinical drug screening reveals clofazimine potentiates the efficacy while reducing the toxicity of anti-PD-1 and CTLA-4 immunotherapy
|
Xue, Gang |
|
|
42 |
5 |
p. 780-796.e6 |
artikel |
4 |
Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer
|
Dyikanov, Daniiar |
|
|
42 |
5 |
p. 759-779.e12 |
artikel |
5 |
Having the cake and eating it? Clofazimine boosts immunotherapy while limiting side effects
|
Kraehenbuehl, Lukas |
|
|
42 |
5 |
p. 738-741 |
artikel |
6 |
Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization
|
Wang, Wenying |
|
|
42 |
5 |
p. 815-832.e12 |
artikel |
7 |
Immunotherapy in resectable NSCLC: Answering the question or questioning the answer?
|
Liu, Si-Yang |
|
|
42 |
5 |
p. 727-731 |
artikel |
8 |
Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes
|
Saliby, Renée Maria |
|
|
42 |
5 |
p. 732-735 |
artikel |
9 |
Molecular subtypes as potential biomarkers in renal cell carcinoma
|
Hage Chehade, Chadi |
|
|
42 |
5 |
p. 736-738 |
artikel |
10 |
Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas
|
Choi, Jaewoo |
|
|
42 |
5 |
p. 833-849.e12 |
artikel |
11 |
Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma
|
Spitzer, Avishay |
|
|
42 |
5 |
p. 904-914.e9 |
artikel |
12 |
Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers
|
Diepstraten, Sarah T. |
|
|
42 |
5 |
p. 850-868.e9 |
artikel |
13 |
Shifting the landscape: The role of IDH inhibitors in glioma cell fate
|
Giacobetti, Skylar A. |
|
|
42 |
5 |
p. 741-743 |
artikel |
14 |
The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia
|
Liu, Mingyang |
|
|
42 |
5 |
p. 885-903.e4 |
artikel |
15 |
Tracking in situ checkpoint inhibitor-bound target T cells in patients with checkpoint-induced colitis
|
Gupta, Tarun |
|
|
42 |
5 |
p. 797-814.e15 |
artikel |
16 |
Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer
|
Niu, Ningning |
|
|
42 |
5 |
p. 869-884.e9 |
artikel |
17 |
Tumor cell-intrinsic epigenetic SETpoint of cancer-associated fibroblasts
|
Chen, Xiongfeng |
|
|
42 |
5 |
p. 744-746 |
artikel |